|Bid||81.55 x 2000|
|Ask||81.80 x 2000|
|Day's Range||84.38 - 86.01|
|52 Week Range||72.33 - 91.79|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.14%|
BSX Stock Recovers after a Robust 4Q17: What's to Come? Boston Scientific released its 4Q17 and 2017 earnings results on February 1, 2018. During its earnings release, the company announced that it expected to relaunch its Lotus device in European and US markets in 2019.
The CPI (consumer price index) measures the changes in prices at a consumer level. The CPI is the weighted average price of a basket of goods and services at the consumer level. The CPI includes food, medical care (XLV), transportation, housing, apparel, recreation, education and communication, and other goods.
The health care sector had a strong run in January 2018. The Health Care Select Sector SPDR ETF (XLV), which tracks the performance of the healthcare sector, rose 5.3% in January 2018. Major health care stocks such as UnitedHealth Group (UNH), Johnson & Johnson (JNJ), Amgen (AMGN), and Pfizer (PFE) returned 7.4%, -1%, 7%, and 2.2%, respectively, in January 2018.
The Health Care Select Sector SPDR (NYSEArca: XLV), the largest exchange traded fund dedicated to the S&P 500’s third-largest sector weight, tumbled last week, but some market observers believe the decline ...
In fiscal 4Q17, Abbott Laboratories(ABT) invested ~6.9% of its total sales in R&D (research and development). In fiscal 2018, the company plans to invest ~7.5% of its total sales. Abbott Laboratories launched more than 20 new products in fiscal 2017. Abbott Laboratories now has an attractive product pipeline, boosted by the recent acquisitions—especially its acquisition of St. Jude Medical.
E-commerce giant Amazon.com (AMZN) has joined forces with Berkshire Hathaway (BRK.A) and JPMorgan Chase (JPM) to create a not-for-profit healthcare company for all US employees in an effort to reduce their workers’ health costs. This is massive news for the healthcare industry, and it could potentially have consequences for health insurers as well as for tech firms that are ready to be acquired by the company or are already partnering with it.
Sirtex Medical Systems is an Australia-based life sciences company with a presence around the globe. The company is focused on interventional oncology therapies and is a global leader in radioembolization. Radioembolization is a minimally invasive therapy for the treatment of liver cancer.
Trump described drug prices as “one of my greatest priorities,” but his administration has released nothing in the way of policy over the last year.
Keith Bliss of Cuttone and Company joins Yahoo Finance's Seana Smith from the floor of the New York Stock Exchange to discuss the latest market action.
Yahoo Finance's Alexis Christoforous and Jared Blikre break down the latest market action after Bristol Myers Squibb reported earnings that beat on earnings and revenue.
Yahoo Finance’s Seana Smith, Dan Roberts and Brittany Jones-Cooper on the Dow’s rebound and if now’s the time to buy.